Health News

An article published early online and in the December edition of The Lancet Oncology reports that if breast cancer patients who receive endocrine treatment develop hot flushes, vasomotor symptoms (such as cold and night sweats), and joint symptoms, then they have a lower likelihood of cancer recurrence. That is, the toxicity of the treatment is acting as an indicator of treatment success.

Read more

Filed under: Women's Health
Tags: Breast Cancer, cancer, Oncology, Women's Health

Related posts

• Why Breast Cancer Is So Poorly Managed In Developing Countries (0)
  Breast cancer is on the rise in developing countries and mortality is high. Now, a consensus Review of cancer experts worldwide, published in this month's issue of The Lancet Oncology, has identified the biggest challenges to diagnosing and treating breast cancer in low-income and middle-income countries (LMCs) and proposed resource-appropriate solutions to improve outcomes... Read more [tags] [...]
  
  
• Study Confirms Long-Lasting Benefit Of Trastuzumab (Herceptin) For Women With Early-Stage Breast Cancer (0)
  Women with an aggressive type of early-stage breast cancer (HER2-positive disease) given trastuzumab (Herceptin) for one year following standard chemotherapy are at significantly less risk of the cancer returning, and the effect is long lasting, according to the long-term results of the landmark HERA trial published Online First in The Lancet Oncology... Read more [tags] Women's Health [...]
  
  
• Study Confirms Long-Lasting Benefit Of Trastuzumab (Herceptin) For Women With Early-Stage Breast Cancer (0)
  Women with an aggressive type of early-stage breast cancer (HER2-positive disease) given trastuzumab (Herceptin) for one year following standard chemotherapy are at significantly less risk of the cancer returning, and the effect is long lasting, according to the long-term results of the landmark HERA trial published Online First in The Lancet Oncology... Read more [tags] Women's Health [...]
  
  
• Recipient Of First-Ever Breast Cancer Fellowship For Gynecologic Oncologists Is Named (0)
  The Society of Gynecologic Oncologists (SGO) and The American College of Obstetricians and Gynecologists have named Marcia M. Humphrey Schmidt, MD, as the initial recipient of their jointly developed Breast Cancer Fellowship for gynecologic oncologists. After completing her fellowship in gynecologic oncology at the University of South Florida in June, Dr... Read more [tags] Women's Health [/tags]
  
  
• Mayo Collaboration Finds Source Of Breast Drug Side Effect (0)
  Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear in the online issue of Journal of Clinical [...]